Cost effectiveness of adjuvant olaparib for BRCA-mutated, early-stage breast cancer Meeting Abstract


Authors: Zettler, C.; De Silva, D.; Blinder, V. S.; Robson, M. E.; Elkin, E. B.
Abstract Title: Cost effectiveness of adjuvant olaparib for BRCA-mutated, early-stage breast cancer
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680301891
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.e17011
Notes: Meeting Abstract: 6593 -- Meeting also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark E Robson
    682 Robson
  2. Elena B Elkin
    163 Elkin
  3. Victoria Susana Blinder
    116 Blinder